Inhibrx Biosciences (INBX) Non Operating Income (2023 - 2025)
Inhibrx Biosciences (INBX) reported Non Operating Income of -$1.9 million for Q4 2025, down 100.09% year-over-year from $2.0 billion in Q4 2024, and down 32.34% quarter-over-quarter from -$1.4 million in Q3 2025.
Inhibrx Biosciences (INBX) Non Operating Income (2023 - 2025) Analysis & Trends
Inhibrx Biosciences (INBX) has 3 years of Non Operating Income data on file, last reported at -$1.9 million in Q4 2025.
- Non Operating Income for Q4 2025 came in at -$1.9 million, down 100.09% year-over-year; the trailing twelve-month figure through Dec 2025 was -$4.7 million (down 100.12% YoY), and the FY2025 annual result was -$5.0 million, down 100.25% from the prior year.
- Non Operating Income retreated to -$1.9 million in Q4 2025 per INBX's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Non Operating Income peaked at $2.0 billion in Q4 2024 and troughed at -$1.9 million in Q4 2025.
- A 3-year average of $368.4 million and a median of -$59000.0 in 2024 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Non Operating Income jumped 930473.73% in 2024, then slumped 149.23% in 2025.
- A 3-year view of Non Operating Income shows it stood at $16.2 million in 2023, then surged by 12333.84% to $2.0 billion in 2024, then plunged by 100.09% to -$1.9 million in 2025.
- Business Quant data shows INBX's Non Operating Income at -$1.9 million in Q4 2025, -$1.4 million in Q3 2025, and -$1.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Inhibrx Biosciences | 186.16 Mn | 186.16 Mn | - | -1.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.91 Mn |
| Sep 30, 2025 | -1.44 Mn |
| Jun 30, 2025 | -1.26 Mn |
| Mar 31, 2025 | -50,000.00 |
| Dec 31, 2024 | 2.02 Bn |
| Sep 30, 2024 | 2.93 Mn |
| Jun 30, 2024 | 2.02 Bn |
| Mar 31, 2024 | -59,000.00 |
| Dec 31, 2023 | 16.24 Mn |
| Sep 30, 2023 | -135,000.00 |
| Jun 30, 2023 | -217,000.00 |